A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.: An article from: Journal of Drugs in Dermatology (Book)$9.95
Herpes zoster vaccine's safety affirmed at 1 year.(Infectious Diseases): An article from: Family Practice News (Book)$9.95
Vaccine approved for shingles in older people.(Zostavax from Merck & Company Inc. approved ): An article from: FDA Consumer (Book)$9.95
Gardasil, Zostavax shots: questions and answers.(Infectious Diseases): An article from: Family Practice News (Book)$9.95
Zostavax elicits antibody response in younger group.(Infectious Diseases): An article from: Family Practice News (Book)$9.95
Herpes zoster vaccine safety sustained at 1 year.(Infectious Diseases): An article from: Skin & Allergy News (Book)$9.95
Safety of herpes zoster vaccine affirmed at 1 year.(Infectious Diseases): An article from: Internal Medicine News (Book)$9.95
Gardasil, Zostavax: the questions patients ask.(Infectious Diseases): An article from: Skin & Allergy News (Book)$9.95
